China / Lockdown Challenges; Biotech Security Debates; Kintor Surges; Fosun Talks Ongoing
As China struggles to maintain its ‘dynamic zero-COVID’ policy in the face of Omicron variant outbreaks, other key talking points emerging from the world’s second-largest healthcare and life sciences market…